New drug may reduce need for blood pressure meds during liver transplants
NCT ID NCT04901169
First seen Mar 23, 2026 · Last updated May 22, 2026 · Updated 7 times
Summary
This study tests if a drug called Angiotensin II can help control blood pressure during liver transplant surgery, reducing the need for other blood pressure medications. It involves 50 adults with severe liver disease who are receiving a liver from a deceased donor. The goal is to see if this approach is safe and effective for managing blood pressure during the operation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER TRANSPLANT; COMPLICATIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of California, San Francisco
San Francisco, California, 94143, United States
Conditions
Explore the condition pages connected to this study.